Efficacy of Isoniazid Prophylaxis in Pediatric Patients at High Risk for LTBI Undergoing Hematopoietic Stem Cell Transplantation - Takeaways - MDSpire

Efficacy of Isoniazid Prophylaxis in Pediatric Patients at High Risk for LTBI Undergoing Hematopoietic Stem Cell Transplantation

  • By

  • Uet Yu

  • Jiaming Yu

  • Xindan Lian

  • Yu Liu

  • Xiaodong Wang

  • Qian Zhang

  • Chunjing Wang

  • Chunlan Yang

  • Yue Li

  • Xiaohui Zhou

  • Xiaoling Zhang

  • Sixi Liu

  • February 2, 2026

  • 0 min

Share

  • 1

    Pediatric HSCT recipients face a significantly higher TB incidence, necessitating effective prophylaxis due to immune suppression.

  • 2

    This study evaluated the efficacy of isoniazid prophylaxis in reducing post-HSCT TB reactivation in high-risk pediatric patients.

  • 3

    A total of 689 patients were analyzed, with 69 classified as LTBI high-risk based on positive IGRA results or radiological evidence.

  • 4

    Isoniazid was administered to high-risk patients starting 5-7 days post-HSCT for 6 months, with regular follow-up for adverse effects.

  • 5

    The study highlights the importance of TB risk stratification and targeted prophylaxis to prevent TB reactivation in vulnerable populations.

Original Source(s)

Related Content